Blog
About

9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Induced pluripotent stem cells with a mitochondrial DNA deletion.

      Stem Cells (Dayton, Ohio)

      Acyl-CoA Dehydrogenase, Long-Chain, deficiency, metabolism, Anemia, Sideroblastic, genetics, pathology, Cell Differentiation, Cell Line, Child, Preschool, DNA, Mitochondrial, Female, Fibroblasts, cytology, physiology, Hematopoietic Stem Cells, Humans, Induced Pluripotent Stem Cells, Lipid Metabolism, Inborn Errors, diagnosis, Mitochondrial Diseases, Muscular Diseases, Sequence Deletion

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In congenital mitochondrial DNA (mtDNA) disorders, a mixture of normal and mutated mtDNA (termed heteroplasmy) exists at varying levels in different tissues, which determines the severity and phenotypic expression of disease. Pearson marrow pancreas syndrome (PS) is a congenital bone marrow failure disorder caused by heteroplasmic deletions in mtDNA. The cause of the hematopoietic failure in PS is unknown, and adequate cellular and animal models are lacking. Induced pluripotent stem (iPS) cells are particularly amenable for studying mtDNA disorders, as cytoplasmic genetic material is retained during direct reprogramming. Here, we derive and characterize iPS cells from a patient with PS. Taking advantage of the tendency for heteroplasmy to change with cell passage, we isolated isogenic PS-iPS cells without detectable levels of deleted mtDNA. We found that PS-iPS cells carrying a high burden of deleted mtDNA displayed differences in growth, mitochondrial function, and hematopoietic phenotype when differentiated in vitro, compared to isogenic iPS cells without deleted mtDNA. Our results demonstrate that reprogramming somatic cells from patients with mtDNA disorders can yield pluripotent stem cells with varying burdens of heteroplasmy that might be useful in the study and treatment of mitochondrial diseases. Copyright © 2013 AlphaMed Press.

          Related collections

          Author and article information

          Journal
          23400930
          3692613
          10.1002/stem.1354

          Comments

          Comment on this article